Home » About SARC » Team
We are researchers and investigators at sarcoma centers working together with pharmaceutical and biotech companies to achieve breakthroughs in sarcoma – to help improve patient outcomes, and ultimately find a cure.
The SARC organization is set up as a directorship, and the organization’s overall strategy and policy is guided by members of the board. Our scientific platform is established by leaders who are recognized experts in sarcoma research. Within this organizational structure we are positioned to bring together the range of expertise needed to move the science of sarcoma forward to develop new and better treatments for patients with sarcoma.
Board of Directors
Scientific Steering Committee
Discovery Translation Committee
SARC Research Advocacy Council
The team of individuals at SARC’s operations office provides the range of expertise needed to support the organization’s scientific leadership and sustain the infrastructure necessary to facilitate the conduct of research.
Contracts Administrator & Executive Assistant
Research Project Manager
Director of Business Operations
Senior Research Project Manager
President & CEO
Under the guidance of the Board of Directors, SARC’s policies and strategies are established and refined on a regular basis. Our board consists of individuals from a range of backgrounds and areas of expertise to ensure that different viewpoints are represented as strategies are crafted to support SARC’s mission. The board meets quarterly, and as needed, to conduct the important business of SARC.
Chair of the Board
Board Member, Corporate Secretary
Board Member, Chief Scientific Officer
Board Member, Corporate Treasurer
SARC Medical Officer
Committee Chair, Chief Scientific Officer
Discovery efforts focus on the pathological mechanisms underpinning common illnesses throughout the body, including cancer. Translational research applies discoveries generated in the laboratory to studies in humans (bench to bedside), or that speeds the adoption of best practices into community settings (bedside to practice).
SARC’s Discovery/Translation Committee’s mandate is to expand SARC’s commitment to discovery and translational sciences. One of the Committee’s most immediate goals is to integrate more science in each SARC clinical trial, explaining why new therapies help some people and not others – this will enable SARC refine the therapeutic approaches, helping more people and reducing needless treatment toxicity.
The SARC Research Advocacy Council was created using the model established by the National Cancer Institute (NCI) for engagement of patient advocates to become “research advocates” across four key functions: advise, design, review, and disseminate. A number of individual patient advocates have agreed to serve as research advocates on the SARC Research Advocacy Council. The council convenes regularly to explore opportunities to interface with researchers.
© 2022 Sarcoma Alliance For Research Through
Sign up for our monthly SARC newsletter and updates on clinical trials.